Shannon N Westin, MD

Trials

Studies that name Shannon N Westin, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:46 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT07318324 · Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

  M.D. Anderson Cancer Center · recruiting · Phase IB, Avutometinib, RAS Pathway · principal investigator
• Ph3
  NCT04269200 · Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

  AstraZeneca · active not recruiting · Endometrial Neoplasms · principal investigator
• Ph2
  NCT02397083 · Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer

  M.D. Anderson Cancer Center · active not recruiting · Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• MD Anderson Gynecologic SPORE for Uterine Cancers
  P50CA098258 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI RUSSELL R BROADDUS, Karen Hsieh Lu · fiscal years 2003 to 2020
  Named on NCT02397083